Experiment 69505

Details

PropertyValue
Pharmacology
Administration routeSUBLINGUAL
OrganismEmpty organism
CitationCARUSO,S: INTELISANO,G: FARINA,M: DI MARI,L: AGNELLO,C: GIAMMUSSO,B:. (2003). EFFICACY AND SAFETY OF DAILY INTAKE OF APOMORPHINE SL IN MEN AFFECTED BY ERECTILE DYSFUNCTION AND MILD HYPERPROLACTINEMIA: A PROSPECTIVE, OPEN-LABEL, PILOT STUDY.. 62(5)
Amount utilized
Compound isolated
DiseaseEFFECTS ON FREQUENCY OF HOT FLUSHES OR OTHER MENOPAUSAL SYMPTOMS. PLACEBO. CHANGE IN MAMMOGRAPHIC BREAST DENSITY, SERUM OESTRADIOL, FSH, LH, MENOPAUSAL SYMPTOMS AND LYMPHOCYTE TYROSINE KINASE ACTIVITY FROM BASELINE TO 12 MONTHS WERE ASSESSED. A TOTAL OF 177 WOMEN COMPLETED THE TRIAL. MAMMOGRAPHIC BREAST AN OPEN LABEL PROSPECTIVE STUDY INVOLVING 20 MEN WITH ERECTILE DYSFUNCTION, PATIENTS WERE TREATED WITH 2-3 MG APOMORPHINE FOR 4 WEEKS SUBLINGUAL. 3 MG/D SIGNIFICANTLY (P<0.02) IMPROVED ERECTILE DYSFUNCTION SUBJECTIVE AND OBJECTIVE SYMPTOMS.
Dose amount3.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
GenderMALE